Lenvatinib Plus Paclitaxel as Second‐Line Therapy for Advanced Gastric Cancer Patients: A Dose Escalation Exploratory Study.
Saved in:
| Title: | Lenvatinib Plus Paclitaxel as Second‐Line Therapy for Advanced Gastric Cancer Patients: A Dose Escalation Exploratory Study. |
|---|---|
| Authors: | Zhou, Chenfei1 (AUTHOR), Jiang, Jinling1 (AUTHOR), Guo, Liting1 (AUTHOR), Xi, Wenqi1 (AUTHOR), Wu, Junwei1 (AUTHOR), Cai, Qu1 (AUTHOR), Ji, Jun2 (AUTHOR), Qi, Feng1 (AUTHOR) qf12486@rjh.com.cn, Zhang, Jun1,3 (AUTHOR) junzhang10977@sjtu.edu.cn |
| Source: | Advanced Science. 10/27/2025, Vol. 12 Issue 40, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
